Medical services benefit the people's livelihood in my country, the five-year survival rate of malignant tumors increases to 40.5%

People's Daily Online, Beijing, April 27 (Reporter Cui Yuanyuan) "Malignant tumors are a serious threat to the health of the people.

What are the results of cancer diagnosis and treatment in my country?

"According to the statistics of the National Cancer Center, with the improvement of medical quality and diagnosis and treatment capabilities, the five-year survival rate of malignant tumors in China has increased from 30.

Jiao Yahui said that the next step will be to pay close attention to the implementation of work tasks, focusing on the standardized diagnosis and treatment of tumors to carry out special rectification work, and continuously improve the level of standardized tumor diagnosis and treatment.

How is the standardized diagnosis and treatment of tumors performed?

"From the perspective of tumor diagnosis and treatment management, quality control is an effective way and means.

One is to strengthen system management.

The second is to improve the professional level.

The third is to promote the homogeneity of diagnosis and treatment.

"Through these work, the diagnosis and treatment of malignant tumors have been further standardized, and the quality of medical care has been continuously improved.

How to treat clinically super-indications and super-guided medications?

Hejie believes that the individual differences of cancer patients are very obvious, and the treatment is also very complicated.

Hejie also emphasized that under the strict supervision of clinical pharmacology institutions and ethics committees, the development of these clinical studies on super-indications and super-treatment guidelines is an innovation in clinical treatment, not over-treatment.

At the same time, in order to promote the standardized diagnosis and treatment of tumors, Jiao Yahui said that this year, special rectification actions of reasonable inspection, rational use of drugs, and reasonable treatment will be carried out in the industry.

How about the use of anti-cancer drugs in the negotiation?

He Jie introduced that the country attaches great importance to the protection of anti-tumor drugs, and through medical insurance negotiations and other methods, the prices of anti-tumor drugs have been drastically reduced to increase the availability of drugs.

"Data from the Anticancer Drug Clinical Application Monitoring Network shows that the average number of anticancer drugs negotiated in hospitals monitored in 2020 has increased by 15% over the previous year, and the average number of inpatients using these drugs has increased by 6%.

Hejie said that in hospitals of different levels and categories, there are differences in the configuration of anti-tumor drugs and the level of drug use, which can be gradually improved and compensated through homogenization.